[
Ascendis Pharma price target raised to $224 on strong Yorvipath demand
[og_img]
https://www.investing.com/news/analyst-ratings/ascendis-pharma-price-target-raised-to-224-on-strong-yorvipath-demand-93CH-4094661
Investing.com
Ascendis Pharma price target raised to $224 on strong Yorvipath demand
Related articles